Results 131 to 140 of about 271,469 (347)

LEFT VENTRICULAR HYPERTROPHY IN TERMS OF SUDDEN CARDIAC DEATH

, 2023
А. В. Барсуков, E. V. Borisova, М.С. Диденко, С.А. Глебова, Армен Владимирович Айрапетян, М.Л. Лигидов, S. D. Rud, Е.И. Асатурова, И.И. Коновалова   +8 more
openalex   +2 more sources

Solving the Riddle of Sudden Cardiac Death in Hypertrophic Cardiomyopathy: The Added Role of Cardiac Magnetic Resonance [PDF]

, 2023
Kamil Stankowski, Stefano Figliozzi, Costanza Lisi, Federica Catapano, Cristina Panico, F. Cannata, Riccardo Mantovani, Antonio Frontera, Renato Bragato, Giulio Stefanini, Lorenzo Monti, Gianluigi Condorelli, Marco Francone   +12 more
openalex   +1 more source

Effects of sodium–glucose co‐transporter inhibitors on individual clinical endpoints and quality of life

ESC Heart Failure, Volume 12, Issue 2, Page 1271-1282, April 2025.
Effects of SGLTi on Individual Clinical Endpoints and Quality‐of‐Life: outcome from randomized data. Abstract Aims Sodium–glucose co‐transporter inhibitors (SGLTis) have cardiovascular protective effects. We aimed to assess the effects of SGLTis on individual hard clinical endpoints and quality of life (QoL) in patients with cardiovascular risk factors.
Jia Liao, Yang Chen, Zhiyu Ling, Helmut Pürerfellner, Martin Martinek, Michael Derndorfer, Johannes Niel, Ramin Ebrahimi, Matthias Heukäufer, Sarah Janschel, Davide Di Vece, Klaus Empen, Astrid Hummel, Bishwas Chamling, Piotr Futyma, Fahim Ebrahimi, Márcio G. Kiuchi, Shaowen Liu, Yuehui Yin, Alexandra Schratter, Willem‐Jan Acou, Philipp Sommer, Boris Schmidt, Julian K. R. Chun, Christian Meyer, Marcus Dörr, Christian Templin, Shaojie Chen   +27 more
wiley   +1 more source

Primary prevention implantable cardioverter-defibrillator and opportunities for sudden cardiac death risk assessment in non-ischaemic cardiomyopathy [PDF]

, 2018
Rajeev K. Pathak, Prashanthan Sanders, Rajat Deo   +2 more
openalex   +1 more source

Considerations for drug trials in hypertrophic cardiomyopathy

ESC Heart Failure, Volume 12, Issue 2, Page 1095-1112, April 2025.
Abstract Hypertrophic cardiomyopathy (HCM) is a heterogeneous condition with potentially serious manifestations. Management has traditionally comprised therapies to palliate symptoms and implantable cardioverter‐defibrillators to prevent sudden cardiac death. The need for disease‐modifying therapies has been recognized for decades.
John P. Farrant, Matthias Schmitt, Anna B. Reid, Clifford J. Garratt, William G. Newman, Aneil Malhotra, Rhys Beynon, Masliza Mahmod, Betty Raman, Robert M. Cooper, Dana Dawson, Thomas Green, Sanjay K. Prasad, Anvesha Singh, Susanna Dodd, Hugh Watkins, Stefan Neubauer, Christopher A. Miller   +17 more
wiley   +1 more source

Association single nucleotide polymorphisms of gene lipid metabolism APOE, HL, SREBP2, USF1 with sudden cardiac death by russian population

Атеросклероз, 2014
Study objective. Investigate the association of polymorphisms E2/E3/E4 gene APOE, rs1800588 gene HL, rs2228314 gene SREBP2, rs2516839 gene USF1 with sudden cardiac death in the Russian population. Materials and methods.
V. N. Maksimov, A. A. Ivanova, P. S. Orlov, E. V. Shakhtchneyder, D. E. Ivanoshchuk, S. V. Savchenko, M. I. Voevoda   +6 more
doaj  

Natural entropy fluctuations discriminate similar looking electric signals emitted from systems of different dynamics

, 2005
Complexity measures are introduced, that quantify the change of the natural entropy fluctuations at different length scales in time-series emitted from systems operating far from equilibrium. They identify impending sudden cardiac death (SD) by analyzing
A. L. Goldberger, A. L. Goldberger, E. S. Skordas, J. S. Richman, M. S. Lazaridou, N. V. Sarlis, P. A. Varotsos, P. A. Varotsos, P. A. Varotsos, P. Laguna, P. Varotsos, R. Jané   +11 more
core   +1 more source

Association of BMI with adherence and outcome in heart failure patients treated with wearable cardioverter defibrillator

ESC Heart Failure, Volume 12, Issue 2, Page 1295-1303, April 2025.
Abstract Background Obesity is a known risk factor for cardiovascular disease (CVD), yet an ‘obesity paradox’ has been observed in various CVD contexts. The impact of obesity on heart failure (HF) patients treated with a wearable cardioverter‐defibrillator (WCD) remains underexplored.
Mohammad Abumayyaleh, Katharina Koepsel, Julia W. Erath, Thomas Kuntz, Norbert Klein, Boldizsar Kovacs, Firat Duru, Ardan M. Saguner, Christian Blockhaus, Dong‐In Shin, Fabienne Kreimer, Michael Gotzmann, Hendrik Lapp, Thomas Beiert, Assem Aweimer, Andreas Mügge, Christel Weiß, Ibrahim El‐Battrawy, Ibrahim Akin   +18 more
wiley   +1 more source

Heart Failure with Preserved Ejection Fraction and Sudden Death: How to Identify High Risk Patients?

Journal of Cardiac Arrhythmias, 2020
Background: Cardiac failure with preserved ejection fraction corresponds to half of the cardiac failure cases, having a similar prognosis to patients with reduced ejection fraction.
Bruno Finkler, Tiago Luiz Luz Leiria, Clovis Fröemming Jr, Javier Pinos, Danilo Barros Zanotta, Marcelo Lapa Kruse, Leonardo Martins Pires, Gustavo Glotz de Lima   +7 more
doaj   +2 more sources

Spotlight on sudden arrhythmic death syndrome

Research Reports in Clinical Cardiology, 2019
David Yuan,1 Hariharan Raju1,2 1Cardiology Department, Concord Repatriation General Hospital, Sydney, Australia; 2Clinical School, Faculty of Medicine and Health, University of Sydney, Sydney, AustraliaCorrespondence: Hariharan RajuCardiology Department,
Yuan D, Raju H
doaj